18 0 2 0 2 B-lower_bound
year 3 7 3 7 I-lower_bound
of 8 10 8 10 O
age 11 14 11 14 B-age
and 15 18 15 18 O
older 19 24 19 24 O

Abnormal 0 8 25 33 O
liver 9 14 34 39 O
function 15 23 40 48 O
as 24 26 49 51 O
defined 27 34 52 59 O
by 35 37 60 62 O
and 38 41 63 66 O
increased 42 51 67 76 O
Alanine 52 59 77 84 B-clinical_variable
transaminase 60 72 85 97 I-clinical_variable
( 73 74 98 99 I-clinical_variable
ALT 74 77 99 102 I-clinical_variable
, 77 78 102 103 I-clinical_variable
) 78 79 103 104 I-clinical_variable
and 80 83 105 108 O
aspartate 84 93 109 118 B-clinical_variable
aminotransferase 94 110 119 135 I-clinical_variable
( 111 112 136 137 I-clinical_variable
AST 112 115 137 140 I-clinical_variable
) 115 116 140 141 I-clinical_variable
that 117 121 142 146 O
is 122 124 147 149 O
greater 125 132 150 157 O
than 133 137 158 162 O
5 138 139 163 164 B-lower_bound
times 140 145 165 170 I-lower_bound
normal 146 152 171 177 I-lower_bound

Abnormal 0 8 178 186 B-chronic_disease
renal 9 14 187 192 I-chronic_disease
function 15 23 193 201 I-chronic_disease

Active 0 6 202 208 O
disease 7 14 209 216 O
( 15 16 217 218 O
CDAI 16 20 218 222 B-clinical_variable
> 21 22 223 224 O
10 23 25 225 227 B-lower_bound
) 25 26 227 228 O

Have 0 4 229 233 O
an 5 7 234 236 O
active 8 14 237 243 B-chronic_disease
infection 15 24 244 253 I-chronic_disease
requiring 25 34 254 263 O
the 35 38 264 267 O
use 39 42 268 271 O
of 43 45 272 274 O
antibiotics 46 57 275 286 B-treatment

Have 0 4 287 291 O
received 5 13 292 300 O
at 14 16 301 303 O
least 17 22 304 309 O
are 23 26 310 313 O
biologic 27 35 314 322 B-treatment
agent 36 41 323 328 I-treatment
for 42 45 329 332 O
at 46 48 333 335 O
least 49 54 336 341 O
6 55 56 342 343 B-lower_bound
months 57 63 344 350 I-lower_bound

Less 0 4 351 355 O
than 5 9 356 360 O
18 10 12 361 363 B-lower_bound
years 13 18 364 369 I-lower_bound
of 19 21 370 372 O
age 22 25 373 376 B-age

May 0 3 377 380 O
or 4 6 381 383 O
may 7 10 384 387 O
not 11 14 388 391 O
be 15 17 392 394 O
receiving 18 27 395 404 O
oral 28 32 405 409 B-treatment
daily 33 38 410 415 I-treatment
steroids 39 47 416 424 I-treatment
( 48 49 425 426 O
less 49 53 426 430 O
than 54 58 431 435 O
or 59 61 436 438 O
equal 62 67 439 444 O
to 68 70 445 447 O
20 71 73 448 450 B-upper_bound
mg 74 76 451 453 I-upper_bound
/ 76 77 453 454 I-upper_bound
day 77 80 454 457 I-upper_bound
) 80 81 457 458 O
of 82 84 459 461 O
prednisone 85 95 462 472 B-treatment
equivalent 96 106 473 483 O

No 0 2 484 486 O
current 3 10 487 494 O
active 11 17 495 501 B-chronic_disease
infections 18 28 502 512 I-chronic_disease
requiring 29 38 513 522 O
antibiotics 39 50 523 534 B-treatment

Patients 0 8 535 543 O
must 9 13 544 548 O
be 14 16 549 551 O
on 17 19 552 554 O
stable 20 26 555 561 O
doses 27 32 562 567 O
of 33 35 568 570 O
RA 36 38 571 573 B-treatment
therapies 39 48 574 583 I-treatment
( 49 50 584 585 O
e.g. 50 54 585 589 O
, 54 55 589 590 O
methotrexate 56 68 591 603 B-treatment
or 69 71 604 606 O
other 72 77 607 612 O
RA 78 80 613 615 O
therapies 81 90 616 625 O
for 91 94 626 629 O
at 95 97 630 632 O
least 98 103 633 638 O
4 104 105 639 640 B-lower_bound
weeks 106 111 641 646 I-lower_bound
prior 112 117 647 652 I-lower_bound
to 118 120 653 655 O
baseline 121 129 656 664 O
visit 130 135 665 670 O
) 135 136 670 671 O

RA 0 2 672 674 B-chronic_disease
diagnosis 3 12 675 684 O
by 13 15 685 687 O
American 16 24 688 696 O
College 25 32 697 704 O
of 33 35 705 707 O
Rheumatology 36 48 708 720 O
criteria 49 57 721 729 O

Uncontrolled 0 12 730 742 O
hypertension 13 25 743 755 B-chronic_disease

Women 0 5 756 761 B-gender
who 6 9 762 765 O
are 10 13 766 769 B-pregnancy
pregnant 14 22 770 778 I-pregnancy

